by Clinical Neuropsychologist | Tuesday, July 9, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Hui‐Chin Chang, Ru‐Yin Tsai, Chen‐Pi Li, Wen‐Chieh Liao,...
by Clinical Neuropsychologist | Monday, July 8, 2024 | Dementia
Abstract INTRODUCTION More robust non-human primate models of Alzheimer’s disease (AD) will provide new opportunities to better understand the pathogenesis and progression of AD. METHODS We designed a CRISPR/Cas9 system to achieve precise genomic deletion of...
by Clinical Neuropsychologist | Sunday, July 7, 2024 | Dementia
Abstract We assessed which coping strategies (problem-focused, emotion-focused, dysfunctional) mediate the association between caregivers’ understanding of dementia as terminal and their distress. A total of 215 caregivers of community-dwelling persons with severe...
by Clinical Neuropsychologist | Saturday, July 6, 2024 | Dementia
Abstract INTRODUCTION We aimed to unravel the underlying pathophysiology of the neurodegeneration (N) markers neurogranin (Ng), neurofilament light (NfL), and hippocampal volume (HCV), in Alzheimer’s disease (AD) using cerebrospinal fluid (CSF) proteomics....
by Clinical Neuropsychologist | Saturday, July 6, 2024 | Dementia
Abstract INTRODUCTION Understanding longitudinal change in key plasma biomarkers will aid in detecting presymptomatic Alzheimer’s disease (AD). METHODS Serial plasma samples from 424 Wisconsin Registry for Alzheimer’s Prevention participants were analyzed...